Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Paclitaxel and IP Carboplatin + Radiation in Advanced Uterine Serous Carcinoma
NCT02112552Phase 2Terminated
- Sponsor
- Albert Einstein College of Medicine
- Start
- Apr 2014
- Primary completion
- Aug 2016
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection, carboplatin in uterine serous carcinoma (USC), sponsored by Albert Einstein College of Medicine. Started Apr 2014; status: terminated.
02
Drugs
Paclitaxel Micelles for Injectioncarboplatin
03
Conditions
uterine serous carcinoma (USC)
Beyond the preview
Go deeper on NCT02112552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02112552.